| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
glial cell derived neurotrophic factor | 0.434 | 0.885 | 0.20 |
|
disease | 0.400 | None | 0.983 | 117 | 0 | 1993 | 2020 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
disease | 0.400 | None | 0.879 | 58 | 0 | 1992 | 2019 | ||||||||
|
Cbl proto-oncogene like 2 | 0.476 | 0.808 |
|
disease | 0.100 | None | 1.000 | 54 | 0 | 2002 | 2019 | |||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 0.980 | 50 | 0 | 1999 | 2020 | ||||||||
|
LDL receptor related protein 2 | 0.491 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0.979 | 47 | 0 | 2010 | 2019 | ||||||||
|
GA binding protein transcription factor subunit alpha | 0.379 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.977 | 43 | 0 | 2006 | 2020 | ||||||||
|
eukaryotic translation elongation factor 1 alpha 2 | 0.554 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0.974 | 39 | 0 | 2004 | 2020 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
disease | 0.100 | None | 0.970 | 33 | 0 | 2016 | 2020 | ||||||||
|
laminin subunit gamma 2 | 0.389 | 0.923 | 2.9E-12 |
|
disease | 0.100 | None | 0.968 | 31 | 0 | 2017 | 2020 | ||||||||
|
dopa decarboxylase | 0.535 | 0.769 | 3.8E-08 |
|
disease | 0.600 | None | 1.000 | 28 | 0 | 1988 | 2019 | ||||||||
|
neurturin | 0.686 | 0.538 | 3.0E-02 |
|
disease | 0.100 | None | 0.964 | 28 | 0 | 2007 | 2020 | ||||||||
|
Parkinson disease 16 (susceptibility) | 0.861 | 0.077 |
|
disease | 0.400 | None | 0.963 | 27 | 0 | 2009 | 2019 | |||||||||
|
myelin protein zero | 0.503 | 0.846 | 0.27 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 2000 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 2005 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 2005 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 2005 | 2020 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
disease | 0.100 | None | 0.957 | 23 | 0 | 2017 | 2020 | ||||||||
|
splicing factor 3b subunit 1 | 0.511 | 0.731 | 1.00 |
|
disease | 0.100 | None | 0.957 | 23 | 0 | 2017 | 2020 | ||||||||
|
platelet activating factor acetylhydrolase 1b regulatory subunit 1 | 0.504 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0.957 | 23 | 0 | 2017 | 2020 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
disease | 0.100 | None | 0.957 | 23 | 0 | 2017 | 2020 | ||||||||
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | 0.530 | 0.692 | 0.98 |
|
disease | 0.100 | None | 0.957 | 23 | 0 | 2017 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 21 | 0 | 2008 | 2020 | ||||||||
|
thyroid peroxidase | 0.455 | 0.846 | 1.8E-21 |
|
disease | 0.100 | None | 1.000 | 21 | 0 | 2007 | 2019 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
disease | 0.100 | None | 1.000 | 21 | 0 | 1999 | 2019 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.400 | None | 0.750 | 20 | 0 | 1999 | 2019 |